Professor Christopher Marshall
Projects as PI
1 of 4
- 3-D printed sources for high-resolution molecular imaging (01/01/2014 - 31/12/2014)
- Advanced FDG PET-CT target volume delineation in intensity modulated radiotherapy planning for head and neck cancers (01/11/2014 - 31/10/2015)
- Assessment of the dopaminergic system in vivo using 18F fallypride PET (05/01/2015 - 15/01/2016)
- Assess the safety and efficacy of intermittent bilateral intraputamenal clial cell line-derived neutrophic factor (GDNF) infusions administered via convection enhanced delivery (CED) in subjects with Parkinson's Disease (19/06/2014 - 30/06/2016)
- Development of Functional neuroimaging pathway for patients with suspected dementia in the ABUHB area enabling access to FDGPET and Amyloid PET scans were appropriate. (01/04/2019 - 31/03/2020)
Projects as Co-Investigator
1 of 2
- 18F-Gemcitabine as diagnostic tool in personalised chemotherapy (01/06/2017 - 31/10/2018)
- IDEA - Integrated DEmentiA research environment (01/04/2015 - 31/03/2016)
- Improving outcomes for patients with pituitary disease: advancing therapeutics and diagnostics using electronic health records and molecular imaging (01/12/2021 - 31/07/2029)
- Longitudinal monitoring of T lymphocyte migration in vivo (01/08/2015 - 31/08/2018)
- Multi-Modal theranostics (MMTs) - towards personalized cancer therapies (01/07/2014 - 30/04/2016)
